Sunrest LifescienceNSE:SUNREST 41 Interest Coverage is 8.93 as of Mar. 2026, which is 69% below its 10-year median of 28.71. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review. Among 454 Healthcare Providers & Services companies, Sunrest Lifescience ranks better than 52.86% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sunrest Lifescience's
Operating Income
for the
six
months ended in Mar. 2026 was ₹62.5 Mil. Sunrest Lifescience's Interest Expense for the
six
months ended in Mar. 2026 was ₹-7.0 Mil.
Sunrest Lifescience's interest coverage for the quarter that ended in Mar. 2026 was 8.93.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sunrest Lifescience's Interest Coverage or its related term are showing as below:
NSE:SUNREST'
s Interest Coverage Range Over the Past 10 Years
Min: 3.71 Med: 28.71 Max: 504.67
Current: 8.93
NSE:SUNREST's Interest Coverage is ranked better than 52.86% of 454
companies
in the Healthcare Providers & Services industry
Industry Median: 8
vs NSE:SUNREST: 8.93
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sunrest Lifescience Interest Coverage Related Terms
Sunrest Lifescience Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sunrest Lifescience's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Pharmaceutical Retailers subindustry, Sunrest Lifescience's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunrest Lifescience Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sunrest Lifescience's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sunrest Lifescience's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunrest Lifescience (NSE:SUNREST) has a Interest Coverage of 8.93 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunrest Lifescience and its competitors. This is 69% below median its historical median of 28.71. Over the past decade, Sunrest Lifescience's Interest Coverage has ranged from 3.71 to 504.67. According to the industry distribution chart, Sunrest Lifescience ranks #214 out of 454 companies in the Healthcare Providers & Services industry, placing it in the top 47.1%.
Is Sunrest Lifescience's Interest Coverage too high?
Sunrest Lifescience's current Interest Coverage of 8.93 is 69% below median its 10-year median of 28.71. Over the past 10 years, this metric has ranged from a low of 3.71 to a high of 504.67. The Healthcare Providers & Services industry median Interest Coverage is 8.00. Sunrest Lifescience's value of 8.93 is 11.6% above this industry median. Based on the distribution chart, Sunrest Lifescience ranks #214 out of 454 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Interest Coverage compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sunrest Lifescience ranks #214 out of 454 companies for Interest Coverage. This puts Sunrest Lifescience in the upper half of its industry. The industry median Interest Coverage is 8.00. Sunrest Lifescience's value of 8.93 is 11.6% above this benchmark. Historically, Sunrest Lifescience's own Interest Coverage has ranged from 3.71 to 504.67 over the past decade. While the company's 10-year median is 28.71 vs. the industry median of 8.00, Sunrest Lifescience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 8.00, based on 454 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunrest Lifescience's current Interest Coverage of 8.93 is 11.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sunrest Lifescience and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunrest Lifescience's current Interest Coverage is 8.93, which is 69% below median its own 10-year median of 28.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Interest Coverage of 8.93. The current Interest Coverage is 8.93, which is 69% below median its 10-year median of 28.71 and 11.6% above the Healthcare Providers & Services industry median of 8.00. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Interest Coverage is 8.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score
Get the complete analysis for NSE:SUNREST
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SUNREST has been successfully added to your 
